Boston Scientific Corp
(XSWX:BSX)
CHF
35.59
-0.43 (-1.21%)
Market Cap: 52.96 Bil
Enterprise Value: 60.90 Bil
PE Ratio: 18.42
PB Ratio: 2.53
GF Score: 74/100 Boston Scientific Corp at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2022 / 01:15PM GMT
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst
Good Morning. I'm happy to kick off day 3 here with Boston Scientific. I'm Robbie Marcus, medtech analyst at JPMorgan. Very happy to introduce Mike Mahoney, the CEO of Boston Scientific. And afterwards in Q&A, we're going to have Dan Brennan and Lauren Tengler join us as well. But with that, Mike, I see you're in San Fran. You're ready to go.
Michael F. Mahoney
Boston Scientific Corporation - Chairman, President & CEO
I am.
Robert Justin Marcus
JPMorgan Chase & Co, Research Division - Analyst
I'll hand it off to you.
Michael F. Mahoney
Boston Scientific Corporation - Chairman, President & CEO
We're planting the flag in support of your meeting here. Well, thank you, Robbie. As you know, it's a -- we feel honored to help represent Boston Scientific at this JPMorgan conference.
For those who are less familiar with it, it's a very exciting company, very innovative, focused
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot